A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
- PMID: 12401529
- DOI: 10.1016/s0002-9343(02)01236-6
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
Abstract
Purpose: To describe the effect of atrial fibrillation on long-term morbidity and mortality.
Subjects and methods: The Renfrew/Paisley Study surveyed 7052 men and 8354 women aged 45-64 years between 1972 and 1976. All hospitalizations and deaths occurring during the subsequent 20 years were analyzed by the presence or absence of atrial fibrillation at baseline. Lone atrial fibrillation was defined in the absence of other cardiovascular signs or symptoms. Cox proportional hazards models were used to adjust for age and cardiovascular conditions.
Results: After 20 years, 42 (89%) of the 47 women with atrial fibrillation had a cardiovascular event (death or hospitalization), compared with 2276 (27%) of the 8307 women without this arrhythmia. Among men, 35 (66%) of 53 with atrial fibrillation had an event, compared with 3151 (45%) of 6999 without atrial fibrillation. In women, atrial fibrillation was an independent predictor of cardiovascular events (rate ratio [RR] = 3.0; 95% confidence interval [CI]: 2.1-4.2), fatal or nonfatal strokes (RR = 3.2; 95% CI: 1.0-5.0), and heart failure (RR = 3.4; 95% CI: 1.9-6.2). The rate ratios among men were 1.8 (95% CI: 1.3-2.5) for cardiovascular events, 2.5 (95% CI: 1.3-4.8) for strokes, and 3.4 (95% CI: 1.7-6.8) for heart failure. Atrial fibrillation was an independent predictor of all-cause mortality in women (RR = 2.2; 95% CI: 1.5-3.2) and men (RR = 1.5; 95% CI: 1.2-2.2). However, lone atrial fibrillation (which occurred in 15 subjects) was not associated with a statistically significant increase in either cardiovascular events (RR = 1.5; 95% CI: 0.6-3.6) or mortality (RR = 1.8; 95% CI: 0.9-3.8).
Conclusions: Atrial fibrillation is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality, especially in women.
Comment in
-
Atrial fibrillation: an old disease, a new epidemic.Am J Med. 2002 Oct 1;113(5):432-5. doi: 10.1016/s0002-9343(02)01245-7. Am J Med. 2002. PMID: 12401540 No abstract available.
Similar articles
-
A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew-Paisley study.Heart. 2006 Dec;92(12):1739-46. doi: 10.1136/hrt.2006.090118. Epub 2006 Jun 28. Heart. 2006. PMID: 16807274 Free PMC article.
-
Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.Am J Kidney Dis. 2008 Feb;51(2):255-62. doi: 10.1053/j.ajkd.2007.10.034. Am J Kidney Dis. 2008. PMID: 18215703
-
Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.Am J Cardiol. 2017 Jun 1;119(11):1785-1790. doi: 10.1016/j.amjcard.2017.02.045. Epub 2017 Mar 16. Am J Cardiol. 2017. PMID: 28395886 Free PMC article. Clinical Trial.
-
Atrial fibrillation in the 21st century: the new cardiac "Cinderella" and new horizons for cardiovascular nursing?Eur J Cardiovasc Nurs. 2002 Jun;1(2):115-21. doi: 10.1016/s1474-5151(02)00010-5. Eur J Cardiovasc Nurs. 2002. PMID: 14622764 Review. No abstract available.
-
Frühe Rhythmuskontrolle bei VHF? : Kardiovaskuläres Risiko -- Autor: H. Holzgreve.MMW Fortschr Med. 2020 Oct;162(17):24-25. doi: 10.1007/s15006-020-4418-4. MMW Fortschr Med. 2020. PMID: 33020858 Review. German. No abstract available.
Cited by
-
Novel P Wave Indices to Predict Atrial Fibrillation Recurrence After Radiofrequency Ablation for Paroxysmal Atrial Fibrillation.Med Sci Monit. 2016 Jul 24;22:2616-23. doi: 10.12659/msm.896675. Med Sci Monit. 2016. PMID: 27450644 Free PMC article.
-
Relationship between exercise induced elevation of left ventricular filling pressure and exercise intolerance in patients with atrial fibrillation.J Geriatr Cardiol. 2016 Sep;13(6):546-51. doi: 10.11909/j.issn.1671-5411.2016.06.016. J Geriatr Cardiol. 2016. PMID: 27582773 Free PMC article.
-
Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option.Front Pharmacol. 2021 Mar 4;12:638445. doi: 10.3389/fphar.2021.638445. eCollection 2021. Front Pharmacol. 2021. PMID: 33897427 Free PMC article. Review.
-
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.Vasc Health Risk Manag. 2012;8:45-57. doi: 10.2147/VHRM.S26482. Epub 2012 Jan 25. Vasc Health Risk Manag. 2012. PMID: 22323896 Free PMC article. Review.
-
Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls.J Interv Card Electrophysiol. 2010 Mar;27(2):95-9. doi: 10.1007/s10840-009-9466-8. Epub 2010 Feb 17. J Interv Card Electrophysiol. 2010. PMID: 20162444
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical